Security key
65343E108
NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC)
CUSIP: 65343E108
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 14,576,884
- Total 13F value
- $11,238,169
- Share change
- -1,691,822
- SEC-reported price per share
- $0.77
- Number of holders
- 45
- Value change
- -$3,082,628
- Number of buys
- 12
- Number of sells
- 19
- Shares outstanding
- 3,602,511
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
45
Top holders
10
NXTC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
NextCure, Inc. SEC filings
NextCure, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 65343E108
Recent filing periods:
Ownership snapshot
Top reported holders of NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sofinnova Investments, Inc.
Disclosed value leader
Sofinnova Investments, Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 74%
Showing 1-6 of 15 holder rows.
Quick read
Sofinnova Investments, Inc. leads the comparable SEC ownership view at 74%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Sofinnova Investments, Inc.'s linked filing trail.
Comparable ownership
Top 5
Sofinnova Investments, Inc.
74%
Logos Global Management LP
69%
Affinity Asset Advisors, LLC
64%
ORBIMED ADVISORS LLC
32%
VANGUARD GROUP INC
27%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sofinnova Investments, Inc. |
13F
Company
|
74%
|
$3,660,443
2,671,856 shares
|
— | 30 Sep 2024 |
| Logos Global Management LP |
13F
Company
|
69%
|
$3,425,000
2,500,000 shares
|
— | 30 Sep 2024 |
| Affinity Asset Advisors, LLC |
13F
Company
|
64%
|
$3,154,559
2,302,598 shares
|
— | 30 Sep 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
32%
|
$1,563,444
1,141,200 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
27%
|
$1,352,634
987,324 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
20%
|
$999,876
729,836 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
45
Shares
14,576,884
Rows available
45
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q4 2024 holders
45
Holder diff
44
| Investor | Q3 2025 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend